Brand Name
Zarontin
Generic Name
Ethosuximide
View Brand Information FDA approval date: September 22, 2000
Classification: Anti-epileptic Agent
Form: Capsule, Solution
What is Zarontin (Ethosuximide)?
Ethosuximide capsule is indicated for the control of absence epilepsy.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
A Comparative Study to Assess Safety and Effectiveness of Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
Summary: Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome